The variability in thickness of the hydrogel coating obtained after the SI-ATRP reaction was assessed by DLS measurements (Malvern Zetasizer Nano ZS) of three different batches of hydrogel-coated nanoshells synthesized in three different SI-ATRP reactions. Average hydrodynamic diameters of the hydrogel-coated nanoshells are displayed in Figure S1 , with coating thicknesses of ~99 nm, ~90 nm, and ~84 nm observed for the three batches. Figure S1 . Z-Average hydrodynamic diameter measurements of three separate batches of hydrogel-coated nanoshells. Bars represent the average ± standard deviation, n=3.
S3. Material Cytotoxicity
For material cytotoxicity analysis, cells were seeded at 4500 cells/well (3T3s, . Material cytotoxicity of hydrogel-coated nanoshells. Viability of 3T3 fibroblasts (blue) and HepG2s (red) exposed to increasing particle concentrations. Cell viability remained >90% in all groups and no statistical significance was observed among any groups.
S4. Doxorubicin loading calculations
Spectra of hydrogel-coated nanoshells at a concentration of 1.2 x 10 9 particles/ml and hydrogel-coated nanoshells loaded with doxorubicin are shown in Figure S4A . The spectrum of the hydrogel-coated nanoshells loaded with doxorubicin contains two distinct peaks: one at 785 nm (as seen in unloaded hydrogel-coated nanoshells) and one at 485 nm (as seen in the spectrum of doxorubicin). Furthermore, these two peaks can be separated by subtracting the hydrogel-coated nanoshells spectrum from the hydrogelcoated nanoshells + doxorubicin spectrum, yielding a spectrum with one peak which closely matches the spectrum of doxorubicin in solution ( Figure S4B ). From these two peaks in the hydrogel-coated nanoshells + doxorubicin spectrum, both the number of particles (estimated using a Mie theory simulation based on the peak at 785 nm) 1 and the amount of doxorubicin loaded into the particles (estimated from the peak at 485 nm and using the concentration curve in Figure S4C ) can be calculated. Figure S4 . Loading of doxorubicin hydrogel-coated nanoshells.
[A] Spectrum of hydrogel-coated nanoshells + doxorubicin (blue) and hydrogel-coated nanoshells at an OD of 0.5 (1.4 x 10 9 particles/ml, red).
[B] The result of subtracting the hydrogel-coated nanoshell spectrum from the hydrogel-coated nanoshell + doxorubicin spectrum (green) closely matches the spectrum of doxorubicin at 0.07 mg/ml (purple).
[C] Standard curve relating absorbance at 485 nm to concentration of doxorubicin in solution.
S5. Doxorubicin release at 37 °C in the presence and absence of serum
Release of doxorubicin from hydrogel-coated nanoshells was assessed at 37 °C in the presence and absence of serum. Hydrogel-coated nanoshells loaded with doxorubicin (~7.1 μg doxorubicin/10 9 particles) were suspended at an OD of 0.5 (1.2 x 10 9 particles/ml) in TBS or TBS + 10% fetal bovine serum (FBS, Atlantic Biologicals) and incubated at 37 °C. After 48 hr, the suspension was filtered through a 0.22 μm polyethersulfone membrane (Genesee Scientific) to separate the doxorubicin-loaded hydrogel-coated nanoshells from the free doxorubicin in the sample. Doxorubicin content of the samples was then determined by measuring absorbance at 485 nm. Approximately 25% of the loaded doxorubicin was released from the particles over the 48 hr period, with the presence of serum not influencing the amount released ( Figure S5 ). Figure S5 . Release of doxorubicin from hydrogel-coated nanoshells at 37 °C. Particles were incubated for 48 hr in the presence and absence of serum. Approximately 25% of the loaded doxorubicin was released from both groups.
